Biliary function and its regulation;La fonction biliaire et sa régulation

Medecine/Sciences

Volumn 20, Issue 12, 2004, Pages 1096-1099

  Poupon, Raoul ^a   Chignard, Nicolas ^a   Rosmorduc, Olivier ^a   Barbu, Véronique ^a   Housset, Chantal ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CARRIER PROTEIN; CHOLESTEROL; URSODEOXYCHOLIC ACID;

BILE; CHOLESTASIS; CHOLESTATIC HEPATITIS; CHOLESTEROL METABOLISM; DRUG DESIGN; FILTRATION; HEPATOBILIARY SYSTEM; HOMEOSTASIS; HUMAN; INTESTINE ABSORPTION; LIPID ABSORPTION; LIVER CELL; LIVER TRANSPLANTATION; MEMBRANE TRANSPORT; OSMOSIS; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; STEROIDOGENESIS;

EID: 10944243143     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200420121096     Document Type: Review

References (15)

1. Jansen PL. From classic bile physiology to cloned transporters. Semin Liver Dis 2001; 20: 245-50.
2. Karpen SJ. Nuclear receptor regulation of hepatic function. J Hepatol 2002; 36: 832-50.
3. Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102: 731-44.
4. Xie W, Radominska-Pandya A, Shi Y, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 2001; 98: 3375-80.
5. Xie W, Yeuh MF, Radominska-Pandya A, et al. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 2003; 100: 4150-55.
6. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93: 693-704.
7. Jacquemin E, Hadchouel M. Genetic basis of progressive familial intrahepatic cholestasis. J Hepatol 1999; 31: 377-81.
8. Rosmorduc O, Hermelin B, Boelle PY, et al. ABCB4 gene mutation associated cholelithiasis in adults. Gastroenterology 2003; 125: 452-9.
9. Dray-Charier N, Paul A, Scoazec JY, et al. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein, and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients. Hepatology 1999; 29: 1624-34.
10. Girodon E, Sternberg D, Chazouilleres O, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with sclerosing cholangitis. J Hepatol 2002; 37: 192-7.
11. Fouassier L, Kinnman N, Lefevre B, et al. Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. J Hepatol 2002; 37: 184-91.
12. Liu Y, Binz J, Numerick MJ, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003; 112: 1678-87.
13. Lee J, Boyer JL. Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis 2000; 20: 373-84.
14. Lee J, Azzaroli F, Wang L, et al. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 2001; 121: 1473-84.
15. Kojima H, Nies AT, Konig J, et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J Hepatol 2003; 39: 3702-5.